Dementia: Living together
People with and without dementia share a common world. Yet, their daily lives are mostly separate. The challenge, however, is not to ignore the...
Helping vulnerable adults and young people in Somerset
Advocacy in Somerset has been a registered charity since 2001 and is also a company limited by guarantee. Our mission has always been to...
Is the UK delivering effective mental health services?
Over the last few months, there has been increasing reports of failures to meet the needs of patients with mental illnesses in the UK....
Congenital Deafblindness: Do you understand me?
Findings on four effective communication interventions for children and adults with congenital deafblindness
Persons (children and adults) with deafblindness express themselves and understand others without...
Social care – fit for purpose
Richard Kramer, Deputy Chief Executive at the Deafblind charity Sense highlights the importance of social care for deafblind and disabled people
Last year was incredibly...
Care in the home
Dominic Carter, Policy Officer at the United Kingdom Homecare Association (UKHCA) details how home care can be more flexible and beneficial to the patient’s needs
Homecare...
Drug discovery backwards?
There’s been a lot written about the slow-down in the marketing of new drugs in the last 20 years from the point of view...
Chemistry helps the fight against bacterial infections
Developing new antibiotics to tackle bacterial infections such as E.coli and MRSA is an important task. Open Access Government highlights how vital this is and...
The many uses of menthol
Phil Richardson a Commercial Consultant to the dermatology industry sheds light on the organic compound menthol, and its role as itch relief
Menthol is used...
HIV-1 vaccine remains the best solution
Professor Tomáš Hanke of the Jenner Institute, University of Oxford discusses why the development of HIV-1 vaccine remains a high global health priority
Since the...
Creating artificial metalloenzymes
Dr Michèle Salmain from Université Pierre et Marie Curie, Paris gives an overview of the process involved in creating artificial enzymes
Artificial enzymes or ‘artzymes’...
Preventing chronic diseases through lifestyle
Chronic diseases account for the vast majority of deaths in European countries. Cardiovascular disease accounts for about 40% of deaths, with about 15% of...
Paediatric Rheumatology in 2015
Paediatric Rheumatology has become recognised within the last 20 years as a paediatric subspecialty. Previously the care of these patients was undertaken by interested...
Embracing 21st Century paediatric rheumatology
Dr Clarissa Pilkington, Consultant in Adolescent and Paediatric Rheumatology at Great Ormond Street Hospital (GOSH) sheds light on paediatric rheumatology and how treatment has improved...
Musculoskeletal disorders in the working population
Vern Putz Anderson from the National Institute for Occupational Safety and Health at the Centers for Disease Control and Prevention (CDC) details the risk...
Predicting drug responses
Luminex xTAG® CYP2D6 Kit v3 and xTAG® CYP2C19 Kit v3 assays may aid in determining therapeutic strategies for drugs metabolized by CYP2D6 and CYP2C19...
Why European health systems must overcome the big challenge
Seemingly unaffected by recent financial crisis and austerity measures, European healthcare keeps improving. Performance, in key terms such as infant mortality, the survival of...
Innovative brain imaging
Energy defects, neuroinflammatory processes, and abnormal cellular morphology in neurodegenerative diseases (ND) would constitute extremely informative brain imaging biomarkers of disease progression and readouts...
Health in Europe: A matter of good economics
Open Access Government details the priorities and intentions of the new European Health Commissioner, Vytenis Andriukaitis
Born in 1951, Vytenis Andriukaitis holds degrees in medicine...
Social care – fit for purpose
Richard Kramer, Deputy Chief Executive at the Deafblind charity Sense highlights the importance of social care for deafblind and disabled people
Last year was incredibly...